Smith et al. (2024) “Impact of metabolic states on SARS-CoV-2 vaccine responses in mouse models of obesity and diabetes” MDPI.
Read about Smith et al. (2024) “Impact of metabolic states on SARS-CoV-2 vaccine responses in mouse models of obesity and diabetes” MDPI.
Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit
Read about Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit
Abt et al. (2024) “Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire” PNAS.
Read about Abt et al. (2024) “Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire” PNAS.
Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone
Read about Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone
Acuitas Therapeutics Honoured With Philanthropic Award
Read about Acuitas Therapeutics Honoured With Philanthropic Award
Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference
Read about Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference
Castruccio Castracani et al. (2024) “An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA” Blood.
Read about Castruccio Castracani et al. (2024) “An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA” Blood.
Chappell et al. (2024) “Use of HSC targeted LNP to generate a mouse model of lethal α-Thalassemia and treatment via lentiviral gene therapy” Blood.
DOI: 10.1182/blood.2023023349
Read about Chappell et al. (2024) “Use of HSC targeted LNP to generate a mouse model of lethal α-Thalassemia and treatment via lentiviral gene therapy” Blood.
Leonard et al. (2024) “Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA” Nature Communications.
DOI: 10.1038/s41467-024-52940-z
Read about Leonard et al. (2024) “Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA” Nature Communications.
PUBLICATION ALERT: Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Read about PUBLICATION ALERT: Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Cohen et al. (2024) “Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals” Cell.
DOI: 10.1016/j.cell.2024.07.052
Read about Cohen et al. (2024) “Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals” Cell.
Alameh et al. (2024) “A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection” Science.
DOI: 10.1126/science.adn4955
Read about Alameh et al. (2024) “A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection” Science.